Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Ema Ruszova"'
Publikováno v:
Life, Vol 14, Iss 5, p 579 (2024)
Our research has developed a highly sensitive and simple assay to detect small amounts of animal and human biological material in less than 40 min. The handheld SaLux19 device developed at the Max Planck Institute of Experimental Medicine in Götting
Externí odkaz:
https://doaj.org/article/c787dd0c4b7b44728f38570a705666d9
Autor:
Ivana Bubancova, Helena Kovarikova, Jan Laco, Ema Ruszova, Ondrej Dvorak, Vladimir Palicka, Marcela Chmelarova
Publikováno v:
International Journal of Molecular Sciences, Vol 18, Iss 2, p 474 (2017)
DNA methylation is well-known to be associated with ovarian cancer (OC) and has great potential to serve as a biomarker in monitoring response to therapy and for disease screening. The purpose of this study was to investigate methylation of HNF1B and
Externí odkaz:
https://doaj.org/article/11bc6ffbdc6c4cc1b0c7c3f5dc8dd4a0
Autor:
Jan Laco, Ema Ruszova, Katerina Hrochova, Ivana Baranova, Marcela Chmelarova, Vladimir Palicka, Eva Dvorakova
Publikováno v:
Pathology & Oncology Research. 25:1457-1465
Epigenetic aberrations are well known to play an important role in carcinogenesis, and also have a great potential to serve as biomarkers in many types of cancers, including ovarian cancer in which sensitive and specific biomarkers and detection meth
Publikováno v:
Acta Medica Martiniana, Vol 15, Iss 3, Pp 5-12 (2015)
Purpose: Our goal was to develop two-tier strategy based on in house-designed methylation specific-duplex polymerase chain reactions (MS-PCRs) that could serve as a relatively simple, cost effective, time efficient approach for molecular screening of
Autor:
Milena Hajzlerova, Lenka Majdiakova, Martina Cermakova, Ema Ruszova, Jiri Kanta, Alena Jiroutová, Rastislav Slavkovsky, Hana Radilova, Irena Hanovcova, Radka Bolehovska
Publikováno v:
Experimental and Toxicologic Pathology. 58:263-273
Hepatic stellate cells (HSC) and liver myofibroblasts (MFB) are two cell populations most likely responsible for the synthesis of most connective tissue components in fibrotic liver. They differ in their origin and location, and possibly in patterns
Autor:
Eva Dvorakova, Ema Ruszova, Jiri Spacek, Spela Kos, Vladimir Palicka, Katerina Hrochova, Jan Laco, Marcela Chmelarova
Publikováno v:
Clinical Chemistry and Laboratory Medicine (CCLM). 52
BACKGROUND Epigenetic changes are considered to be a frequent event during tumor development. Various methylation changes have been identified and show promise as potential cancer biomarkers. The aim of this study was to investigate promoter methylat